Assessment of postvaccination neutralizing antibodies response against sars-cov-2 in cancer patients under treatment with targeted agents

HIGHLIGHTS

  • who: Flora Zagouri and collaborators from the Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece have published the Article: Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents, in the Journal: Vaccines 2022, 10, 1474. of 31/08/2022
  • what: More specifically, the authors report the levels of neutralizing antibodies (NAb) against SARS-CoV-2 in patients with prostate, breast cancer and ovarian cancer under treatment in comparison to healthy controls. Under this perspective the authors present in the current . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?